Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health www.cancer.gov

Navigation

Personal tools

You are here: Home / Biomarkers / TNFRSF25

TNFRSF25

Basics

Aliases:
This biomarker is also known as:
  • tumor necrosis factor receptor superfamily, member 12 (translocating chain-association membrane protein),
  • TRAMP,
  • WSL,
  • Death receptor 3,
  • LARD,
  • death domain receptor 3 soluble form,
  • TNFRSF12,
  • apoptosis inducing receptor,
  • Apoptosis-inducing receptor AIR,
  • WSL1,
  • TR-3,
  • DDR3,
  • tumor necrosis factor receptor superfamily member 25,
  • WSL-LR,
  • APO3,
  • APO-3,
  • Apo-3,
  • Apoptosis-mediating receptor TRAMP,
  • Protein WSL-1,
  • Apoptosis-mediating receptor DR3,
  • tumor necrosis factor receptor superfamily, member 25,
  • Lymphocyte-associated receptor of death,
  • death receptor beta,
  • DR3,
  • WSL-1,

View in BioMuta

Description…

The TNFRSF25 gene product is a member of the TNF-receptor superfamily. TNFRSF25 protein is a receptor for TNFSF12/APO3L/TWEAK. It mediates activation of NF-kappa-B and induces apoptosis. TNFRSF25 may also play a role in regulating lymphocyte homeostatsis. There are many alternatively spliced transcript variants encoding different isoforms of this protein.

Attributes

QA State: Under Review
Type: Gene
Short Name:
HGNC Name: TNFRSF25

Datasets

There are no datasets associated with this biomarker.

Organs

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Studies

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Publications

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Resources

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

2015 Steering Committee Meeting

The next EDRN Steering Committee Meeting will take place March 31st through April 2nd, 2015, in Atlanta, Georgia.

Announcement 12/02/2014

New Round of EDRN FOAs

The RFAs for EDRN have been released:
- Biomarker Developmental Laboratories (U01),
- Clinical Validation Centers (U01),
- Biomarker Reference Laboratories (U24),
- Data Management and Coordinating Center (U24).

EDRN Renewal flyer NOTE-New receipt deadline for applications submitted for all EDRN FOAs is January 20, 2015, by 5:00 PM local time of applicant organization.

There will be a Pre-Application webinar to discuss each of the four individual EDRN FOAs on Tuesday, December 2nd, 2014, from 1pm-5pm (Eastern). Potential applicants interested in participating in the webinar should send a message to Dr. Sharmistha Ghosh (ghoshjanjigias@mail.nih.gov) no later than 5:00 p.m. (EST) November 21, 2014. Please mention the FOA of interest in the subject line.

Announcement 10/07/2014

EDRN Patient Advocates will host an EDRN Advocacy Educational Webinar, Biomarkers for Prostate Cancer Detection and Monitoring, on Monday, January 12th, 2015, at 1 p.m. EDT / 10 a.m. PDT. Registration is not required for this. Please click for more information.